Forearm swelling with paraesthesia needs compartment escalation and coagulation tests before aspirin or minor trauma explains the bleeding.
Isolated prolonged activated partial thromboplastin time with bleeding needs explanation.
Forearm pain, swelling, paraesthesia and repeated haematomas after minor trauma should make the activated partial thromboplastin time matter immediately. Acquired haemophilia A should come first because the next action is concrete: check platelet count, prothrombin time and activated partial thromboplastin time early, treat an isolated prolonged result as pivotal, and escalate a tense painful limb with pain on passive stretch for compartment syndrome rather than waiting for complete haematology results.
Retained ballistic fragments add another injury-aftercare problem: location, removal rationale, blood lead surveillance, chain of custody and psychological distress need documentation. Paediatric hepatitis C brings timing to the foreground, because infant RNA testing and later antibody testing answer different questions. Respiratory biomarkers, pancreatic radiotherapy, the interstitium and Gen Z teaching each reward concrete documentation: exacerbation subtype, toxicity plan, mechanism uncertainty and feedback expectations.
Major soft-tissue bleeding after minor trauma plus isolated prolonged activated partial thromboplastin time should change the plan. Recurrent haematomas need coagulation testing, mixing studies and factor assays, while a tense painful forearm with paraesthesia or passive-stretch pain needs immediate surgical escalation.
Gunshot wound discharge planning should not end with “fragment retained”. Record location, removal rationale, return symptoms and surveillance needs. Intra-articular, cerebrospinal fluid, bone marrow, vascular, multiple or symptomatic fragments lower the threshold for blood lead follow-up.
A baby born to a mother with detectable hepatitis C RNA needs age-appropriate testing and clear family advice. RNA testing can diagnose earlier, while antibody testing before 18 months may reflect maternal antibodies rather than infant infection.
Recurrent asthma or COPD exacerbations should not be reduced to a single biomarker. Blood eosinophils and FeNO need interpretation alongside symptoms, exacerbation subtype, smoking status, inhaled corticosteroid exposure, treatment changes and adherence uncertainty.
When and how to pause, observe, and escalate or de-escalate in patients with devastating brain injury-uncertainty, prognostication, ethics, and communication.
The interstitium is presented as a connected extravascular fluid network rather than isolated tissue water. It offers a basic-science frame for oedema, fascia, gut-liver signalling and pancreatic cancer research, while keeping emerging hypotheses separate from established mechanisms.
Feedback difficulty is not automatically a generational problem. Clarify expectations, communication channels, feedback cadence and learning preferences early, then use curiosity, psychological safety and observable behaviours before concluding that a learner is resistant.
When a patient presents with major soft-tissue bleeding after minor trauma, do not stop at the injury story or aspirin. Check platelet count, prothrombin time and activated partial thromboplastin time early, and treat an isolated prolonged result as pivotal. The coagulopathy topic gives the bedside sequence for bleeding plus compartment symptoms.
Which coagulation result should change the plan in unexplained soft-tissue bleeding?
An isolated markedly prolonged activated partial thromboplastin time needs explanation, especially when bleeding is recurrent or disproportionate. Mixing studies, factor assays, von Willebrand studies and inhibitor titre help define an acquired inhibitor.
What limb findings should trigger immediate surgical escalation?
A tense painful limb with paraesthesia or pain on passive stretch should be treated as possible compartment syndrome. Palpable or Dopplerable pulses do not exclude dangerous compartment pressure.
What should be documented when ballistic fragments remain in place?
Record fragment location, removal rationale, risk-benefit discussion, surveillance plan and return symptoms. Follow-up should include pain, infection, function, mood symptoms and blood lead surveillance when fragment risk is higher.
.svg)